URMC-099 is an orally bioavailable, brain penetrant mixed lineage kinase (MLK) inhibitor with IC50 of 19 nM, 42 nM, 14 nM, and 150 nM, for MLK1, MLK2, MLK3, and DLK, respectively.
More Information Supplier PageURMC-099 is an orally bioavailable, brain penetrant mixed lineage kinase (MLK) inhibitor with IC50 of 19 nM, 42 nM, 14 nM, and 150 nM, for MLK1, MLK2, MLK3, and DLK, respectively.
More Information Supplier PageMI-3 is a potent menin-MLL interaction inhibitor with IC50 of 648 nM.
More Information Supplier PageMI-3 is a potent menin-MLL interaction inhibitor with IC50 of 648 nM.
More Information Supplier PageMI-3 is a potent menin-MLL interaction inhibitor with IC50 of 648 nM.
More Information Supplier PageMI-3 is a potent menin-MLL interaction inhibitor with IC50 of 648 nM.
More Information Supplier PageLY2119620 is a specific, and allosteric agonist of human M2 and M4 muscarinic acetylcholine receptors.
More Information Supplier PageLY2119620 is a specific, and allosteric agonist of human M2 and M4 muscarinic acetylcholine receptors.
More Information Supplier PageURMC-099 is an orally bioavailable, brain penetrant mixed lineage kinase (MLK) inhibitor with IC50 of 19 nM, 42 nM, 14 nM, and 150 nM, for MLK1, MLK2, MLK3, and DLK, respectively.
More Information Supplier PageMG-101 (ALLN) is a cell-permeable and potent inhibitor of cysteine proteases including calpains and lysosomal cathepsins.
More Information Supplier Page
